Literature DB >> 20694216

Droplet-based microfluidic system for multicellular tumor spheroid formation and anticancer drug testing.

Linfen Yu1, Michael C W Chen, Karen C Cheung.   

Abstract

Creating multicellular tumor spheroids is critical for characterizing anticancer treatments since it may provide a better model than monolayer culture of tumor cells. Moreover, continuous dynamic perfusion allows the establishment of long term cell culture and subsequent multicellular spheroid formation. A droplet-based microfluidic system was used to form alginate beads with entrapped breast tumor cells. After gelation, the alginate beads were trapped in microsieve structures for cell culture in a continuous perfusion system. The alginate environment permitted cell proliferation and the formation of multicellular spheroids was observed. The dose-dependent response of the tumor spheroids to doxorubicin, and anticancer drug, showed multicellular resistance compared to conventional monolayer culture. The microsieve structures maintain constant location of each bead in the same position throughout the device seeding process, cell proliferation and spheroid formation, treatment with drug, and imaging, permitting temporal and spatial tracking.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20694216     DOI: 10.1039/c004590j

Source DB:  PubMed          Journal:  Lab Chip        ISSN: 1473-0189            Impact factor:   6.799


  40 in total

1.  On-chip three-dimensional tumor spheroid formation and pump-less perfusion culture using gravity-driven cell aggregation and balanced droplet dispensing.

Authors:  Taeyoon Kim; Il Doh; Young-Ho Cho
Journal:  Biomicrofluidics       Date:  2012-07-24       Impact factor: 2.800

Review 2.  Strategies for improving the physiological relevance of human engineered tissues.

Authors:  Rosalyn D Abbott; David L Kaplan
Journal:  Trends Biotechnol       Date:  2015-04-30       Impact factor: 19.536

3.  Perspective: Flicking with flow: Can microfluidics revolutionize the cancer research?

Authors:  Tamal Das; Suman Chakraborty
Journal:  Biomicrofluidics       Date:  2013-01-31       Impact factor: 2.800

4.  Electrocoalescence based serial dilution of microfluidic droplets.

Authors:  Biddut Bhattacharjee; Siva A Vanapalli
Journal:  Biomicrofluidics       Date:  2014-07-29       Impact factor: 2.800

5.  Core-shell hydrogel beads with extracellular matrix for tumor spheroid formation.

Authors:  L Yu; S M Grist; S S Nasseri; E Cheng; Y-C E Hwang; C Ni; K C Cheung
Journal:  Biomicrofluidics       Date:  2015-04-17       Impact factor: 2.800

6.  On chip two-photon metabolic imaging for drug toxicity testing.

Authors:  Fang Yu; Shuangmu Zhuo; Yinghua Qu; Deepak Choudhury; Zhiping Wang; Ciprian Iliescu; Hanry Yu
Journal:  Biomicrofluidics       Date:  2017-05-11       Impact factor: 2.800

7.  Microfluidics platform for measurement of volume changes in immobilized intestinal enteroids.

Authors:  Byung-Ju Jin; Sailaja Battula; Nick Zachos; Olga Kovbasnjuk; Jennifer Fawlke-Abel; Julie In; Mark Donowitz; Alan S Verkman
Journal:  Biomicrofluidics       Date:  2014-04-01       Impact factor: 2.800

8.  Comparative Study of Multicellular Tumor Spheroid Formation Methods and Implications for Drug Screening.

Authors:  Maria F Gencoglu; Lauren E Barney; Christopher L Hall; Elizabeth A Brooks; Alyssa D Schwartz; Daniel C Corbett; Kelly R Stevens; Shelly R Peyton
Journal:  ACS Biomater Sci Eng       Date:  2017-03-13

9.  Microfluidic assembly of hydrogel-based immunogenic tumor spheroids for evaluation of anticancer therapies and biomarker release.

Authors:  Pooja Sabhachandani; Saheli Sarkar; Seamus Mckenney; Dashnamoorthy Ravi; Andrew M Evens; Tania Konry
Journal:  J Control Release       Date:  2018-12-12       Impact factor: 9.776

Review 10.  Organ-on-a-chip platforms for studying drug delivery systems.

Authors:  Nupura S Bhise; João Ribas; Vijayan Manoharan; Yu Shrike Zhang; Alessandro Polini; Solange Massa; Mehmet R Dokmeci; Ali Khademhosseini
Journal:  J Control Release       Date:  2014-05-10       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.